Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Holmlin R. Erik, Chairman & CEO. Insider active across 3 companies, notably Bionano Genomics, Inc. In total, 12 filings have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €24k. History available since 12 May 2021. The latest transaction was disclosed on 14 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
R. Erik Holmlin is President and CEO of Bionano Genomics, Inc. He is responsible for the strategic and operational leadership of the company, overseeing all activities to ensure growth and innovation. With extensive experience in the biotechnology sector, he plays a key role in shaping the company's vision and objectives. His leadership is essential for navigating a competitive environment.